Marshall Islands vs New Zealand: Immunization, HepB3
Marshall Islands
89.0%
in 2024
New Zealand
89.0%
in 2024
Marshall Islands rank
102nd
New Zealand rank
102nd
Immunization, HepB3 over time
- Marshall Islands
- New Zealand
How they compare
Marshall Islands currently reports 89.0% against 89.0% in New Zealand, a difference of 0.0%.
The two have swapped places 4 times across 33 shared years of data; in 1992 it was New Zealand ahead.
Marshall Islands ranks 102nd and New Zealand ranks 102nd of 188 countries.
New Zealand has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Marshall Islands | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 54.0% | 84.9% | 30.9% | New Zealand |
| 2000s | 81.5% | 89.1% | 7.6% | New Zealand |
| 2010s | 83.1% | 92.7% | 9.6% | New Zealand |
| 2020s | 88.0% | 89.6% | 1.6% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Marshall Islands or New Zealand?
- Marshall Islands, at 89.0% against 89.0% in New Zealand as of 2024.
- What is the difference in immunization, hepb3 between Marshall Islands and New Zealand?
- 0.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and New Zealand?
- 33 years are reported by both, from 1992 to 2024.
- How do Marshall Islands and New Zealand rank globally for immunization, hepb3?
- Marshall Islands ranks 102nd and New Zealand ranks 102nd of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.